APAC の空間ゲノミクスおよびトランスクリプトミクス市場は、2022 年の 6,400 万ドルから 2027年までに1 億 5,200 万ドルに成長し、予測期間中のCAGRは18.9% になると予測されます。アジア太平洋地域の空間ゲノミクスとトランスクリプトミクスの市場は高度に統合されており、主要なプレーヤーは市場シェアを獲得するために戦略を練っています。アジア太平洋地域の空間ゲノミクスおよびトランスクリプトミクス市場の著名なプレーヤーは以下の通り:NanoString Technologies, Inc. (米国)、10X Genomics (米国)、Illumina (米国)、Bio-Rad Laboratories (米国)、Bio-Techne Corporation (米国)、Standard BioTools Inc. (米国)、Akoya Biosciences, Inc. (米国)、PerkinElmer, Inc. (米国)、S2 Genomics, Inc. (米国)、Cantata Bio (米国)、Vizgen Corporation (米国)、BGI (中国)、Miltenyi Biotec (ドイツ)、Bruker (米国)、PerkinElmer Inc. (米国)、Novogene Co., Ltd. (中国)。
目次
TABLE OF CONTENTS
1 INTRODUCTION (Page No. - 17)
1.1 STUDY OBJECTIVES?
1.2 MARKET DEFINITION?
1.2.1 INCLUSIONS AND EXCLUSIONS
1.3 STUDY SCOPE?
1.4 YEARS CONSIDERED?
1.5 CURRENCY CONSIDERED?
1.6 LIMITATIONS?
1.7 STAKEHOLDERS?
2 RESEARCH METHODOLOGY (Page No. - 20)
2.1 RESEARCH DATA?
FIGURE 1 RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.2 PRIMARY DATA
FIGURE 2 BREAKDOWN OF PRIMARIES: ASIA PACIFIC SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET
2.2 MARKET ESTIMATION METHODOLOGY?
FIGURE 3 MARKET SIZE ESTIMATION (COMPANY REVENUE ANALYSIS-BASED ESTIMATION)
FIGURE 4 ASIA PACIFIC SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET SIZE (USD MILLION)
FIGURE 5 ASIA PACIFIC SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET: FINAL CAGR PROJECTIONS (2022−2027)
FIGURE 6 ASIA PACIFIC SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET: CAGR PROJECTIONS FROM ANALYSIS OF DEMAND-SIDE DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
2.3 MARKET DATA ESTIMATION AND TRIANGULATION?
FIGURE 7 DATA TRIANGULATION METHODOLOGY
2.4 INDUSTRY INSIGHTS?
2.5 RESEARCH ASSUMPTIONS?
3 EXECUTIVE SUMMARY (Page No. - 27)
FIGURE 8 ASIA PACIFIC SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY PRODUCT, 2022 VS. 2027 (USD MILLION)
FIGURE 9 ASIA PACIFIC SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY TECHNIQUE, 2022 VS. 2027 (USD MILLION)
FIGURE 10 ASIA PACIFIC SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY APPLICATION, 2022 VS. 2027 (USD MILLION)
FIGURE 11 ASIA PACIFIC SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY END USER, 2022 VS. 2027 (USD MILLION)
FIGURE 12 ASIA PACIFIC SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET SHARE, BY COUNTRY, 2021
4 PREMIUM INSIGHTS (Page No. - 31)
4.1 ASIA PACIFIC SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET OVERVIEW?
FIGURE 13 REDUCED COST OF NEXT-GENERATION SEQUENCING TO DRIVE MARKET GROWTH
4.2 JAPAN: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET SHARE, BY PRODUCT (2021)?
FIGURE 14 CONSUMABLES SEGMENT DOMINATED MARKET IN JAPAN
4.3 CHINA: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET SHARE, BY APPLICATION (2021)?
FIGURE 15 TRANSLATIONAL RESEARCH SEGMENT DOMINATED MARKET IN CHINA
5 MARKET OVERVIEW (Page No. - 33)
5.1 INTRODUCTION?
5.2 MARKET DYNAMICS?
FIGURE 16 ASIA PACIFIC SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
TABLE 1 ASIA PACIFIC SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET: IMPACT ANALYSIS
5.2.1 DRIVERS
5.2.1.1 Reduced cost of next-generation sequencing
5.2.1.2 Increasing adoption of spatial genomics and transcriptomics in drug discovery and development
5.2.2 RESTRAINTS
5.2.2.1 High capital investments
5.2.3 OPPORTUNITIES
5.2.3.1 Increasing demand for single-cell analysis
5.2.4 CHALLENGES
5.2.4.1 Analytical limitations associated with spatial techniques
5.3 TECHNOLOGY ANALYSIS?
TABLE 2 FIVE BENCHMARK COMPUTATIONAL METHODS: COMPARATIVE ANALYSIS
5.4 VALUE CHAIN ANALYSIS?
TABLE 3 INDICATIVE LIST OF DISTRIBUTORS FOR KEY MARKET PLAYERS IN ASIA PACIFIC
FIGURE 17 ASIA PACIFIC SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET: VALUE CHAIN ANALYSIS
5.5 ECOSYSTEM ANALYSIS?
FIGURE 18 SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET: ECOSYSTEM ANALYSIS
5.6 PORTER’S FIVE FORCES ANALYSIS?
TABLE 4 ASIA PACIFIC SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET: PORTER’S FIVE FORCES ANALYSIS
5.6.1 THREAT OF NEW ENTRANTS
5.6.2 THREAT OF SUBSTITUTES
5.6.3 BARGAINING POWER OF BUYERS
5.6.4 BARGAINING POWER OF SUPPLIERS
5.6.5 INTENSITY OF COMPETITIVE RIVALRY
5.7 REGULATORY ANALYSIS?
5.7.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 5 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.8 PRICING ANALYSIS?
TABLE 6 PRODUCT PRICING: KEY MARKET PLAYERS
5.8.1 AVERAGE SELLING PRICE TREND
5.9 KEY CONFERENCES AND EVENTS (2020-2023)?
TABLE 7 SPATIAL GENOMICS AND TRANSCRIPTOMICS CONFERENCES (2020-2023)
5.10 KEY STAKEHOLDERS AND BUYING CRITERIA?
5.10.1 KEY STAKEHOLDERS IN BUYING PROCESS
FIGURE 19 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS
5.10.2 BUYING CRITERIA FOR SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET IN ASIA PACIFIC REGION
FIGURE 20 KEY BUYING CRITERIA FOR END USERS
6 ASIA PACIFIC SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY PRODUCT (Page No. - 44)
6.1 INTRODUCTION?
TABLE 8 ASIA PACIFIC: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
6.2 CONSUMABLES?
6.2.1 GROWING USE OF CONSUMABLES FOR VARIOUS SPATIAL GENOMICS AND TRANSCRIPTOMICS APPLICATIONS TO DRIVE GROWTH
TABLE 9 ASIA PACIFIC: SPATIAL GENOMICS AND TRANSCRIPTOMICS CONSUMABLES MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
6.3 INSTRUMENTS?
6.3.1 INTRODUCTION OF NOVEL INSTRUMENTS TO DRIVE MARKET
TABLE 10 ASIA PACIFIC: SPATIAL GENOMICS AND TRANSCRIPTOMICS INSTRUMENTS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
6.4 SOFTWARE?
6.4.1 RISING USE OF SPATIAL OMICS FOR DISEASE DIAGNOSIS TO PROPEL DEMAND FOR SOFTWARE
TABLE 11 ASIA PACIFIC: SPATIAL GENOMICS AND TRANSCRIPTOMICS SOFTWARE MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
7 SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY TECHNIQUE (Page No. - 48)
7.1 INTRODUCTION?
TABLE 12 ASIA PACIFIC: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY TECHNIQUE, 2020-2027 (USD MILLION)
7.2 SPATIAL TRANSCRIPTOMICS?
TABLE 13 ASIA PACIFIC: SPATIAL TRANSCRIPTOMICS MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 14 ASIA PACIFIC: SPATIAL TRANSCRIPTOMICS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
7.2.1 IMMUNOHISTOCHEMISTRY
7.2.1.1 Emergence of mIHC/IF to propel growth
TABLE 15 ASIA PACIFIC: IMMUNOHISTOCHEMISTRY MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
7.2.2 IN SITU HYBRIDIZATION
7.2.2.1 High adoption of MERFISH to drive growth
TABLE 16 ASIA PACIFIC: IN SITU HYBRIDIZATION MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
7.2.3 SPATIAL TRANSCRIPTOMIC SEQUENCING
TABLE 17 ASIA PACIFIC: SPATIAL TRANSCRIPTOMIC SEQUENCING MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
7.2.3.1 Microdissection-based sequencing
7.2.3.1.1 Increasing use of microdissection-based sequencing to contribute to market growth
7.2.3.2 In situ sequencing
7.2.3.2.1 Increased adoption of in situ sequencing likely to boost market growth
7.2.3.3 Other sequencing technologies
7.2.4 MICROSCOPY-BASED RNA IMAGING
7.2.4.1 Increasing use of microscopy-based RNA imaging in cancer research and diagnosis to drive growth
TABLE 18 ASIA PACIFIC: MICROSCOPY-BASED RNA IMAGING MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
7.2.5 OTHER SPATIAL TRANSCRIPTOMICS TECHNIQUES
TABLE 19 ASIA PACIFIC: SPATIAL TRANSCRIPTOMICS MARKET FOR OTHER TECHNIQUES, BY COUNTRY, 2020-2027 (USD MILLION)
7.3 SPATIAL GENOMICS ANALYSIS?
TABLE 20 ASIA PACIFIC: SPATIAL GENOMICS ANALYSIS MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 21 ASIA PACIFIC: SPATIAL GENOMICS ANALYSIS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
7.3.1 FLUORESCENCE IN SITU HYBRIDIZATION
7.3.1.1 Emerging potential of spatial genomics analysis in cancer diagnostics to support growth
TABLE 22 ASIA PACIFIC: FLUORESCENCE IN SITU HYBRIDIZATION MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
7.3.2 SPATIAL GENOMIC SEQUENCING
7.3.2.1 Rising adoption of massively parallel sequencing to drive growth
TABLE 23 ASIA PACIFIC: SPATIAL GENOMIC SEQUENCING MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
7.3.3 OTHER SPATIAL GENOMICS ANALYSIS TECHNIQUES
TABLE 24 ASIA PACIFIC: OTHER SPATIAL GENOMICS ANALYSIS TECHNIQUES MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
8 ASIA PACIFIC SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY APPLICATION (Page No. - 58)
8.1 INTRODUCTION?
TABLE 25 ASIA PACIFIC: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
8.2 TRANSLATIONAL RESEARCH?
8.2.1 DEMAND FOR SPATIAL TRANSCRIPTOMICS IN UNDERSTANDING TUMOR MICROENVIRONMENT TO DRIVE GROWTH
TABLE 26 ASIA PACIFIC: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET FOR TRANSLATIONAL RESEARCH, BY COUNTRY, 2020-2027 (USD MILLION)
8.3 DRUG DISCOVERY AND DEVELOPMENT?
8.3.1 RISING USE OF RNA-SEQ IN DRUG DISCOVERY TO DRIVE GROWTH
TABLE 27 ASIA PACIFIC: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET FOR DRUG DISCOVERY AND DEVELOPMENT, BY COUNTRY, 2020-2027 (USD MILLION)
9 ASIA PACIFIC SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY END USER (Page No. - 62)
9.1 INTRODUCTION?
TABLE 28 ASIA PACIFIC: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY END USER, 2020-2027 (USD MILLION)
9.2 ACADEMIC AND RESEARCH INSTITUTES?
9.2.1 INCREASING DEMAND FOR SPATIAL GENOMICS AND TRANSCRIPTOMICS IN TRANSLATIONAL RESEARCH TO DRIVE GROWTH
TABLE 29 ASIA PACIFIC: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY, 2020-2027 (USD MILLION)
9.3 CONTRACT RESEARCH ORGANIZATIONS?
9.3.1 INCREASING NUMBER OF CROS FORMING STRATEGIC PARTNERSHIPS WITH GENOMICS PROVIDERS TO DRIVE GROWTH
TABLE 30 ASIA PACIFIC: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2020-2027 (USD MILLION)
9.4 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES?
9.4.1 GROWING IMPORTANCE OF BIOMARKERS TO DRIVE DEMAND FOR SPATIAL GENOMICS AND TRANSCRIPTOMICS SYSTEMS
TABLE 31 ASIA PACIFIC: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2020-2027 (USD MILLION)
10 ASIA PACIFIC SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY COUNTRY (Page No. - 66)
10.1 INTRODUCTION?
TABLE 32 ASIA PACIFIC: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
10.2 CHINA?
10.2.1 INCREASING R&D SPENDING BY GOVERNMENT AND BIOPHARMA COMPANIES TO SUPPORT MARKET GROWTH
TABLE 33 CHINA: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY TECHNIQUE, 2020-2027 (USD MILLION)
TABLE 34 CHINA: SPATIAL TRANSCRIPTOMICS MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 35 CHINA: SPATIAL GENOMICS ANALYSIS MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 36 CHINA: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
TABLE 37 CHINA: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
TABLE 38 CHINA: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY END USER, 2020-2027 (USD MILLION)
10.3 JAPAN?
10.3.1 RISING FUNDING IN JAPAN TO BOOST RESEARCH APPLICATIONS
TABLE 39 JAPAN: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY TECHNIQUE, 2020-2027 (USD MILLION)
TABLE 40 JAPAN: SPATIAL TRANSCRIPTOMICS MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 41 JAPAN: SPATIAL GENOMICS ANALYSIS MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 42 JAPAN: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
TABLE 43 JAPAN: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
TABLE 44 JAPAN: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY END USER, 2020-2027 (USD MILLION)
10.4 INDIA?
10.4.1 COLLABORATIONS BETWEEN HOSPITALS AND DIAGNOSTIC CENTERS FOR LABORATORY SERVICES TO BOOST GROWTH
TABLE 45 INDIA: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY TECHNIQUE, 2020-2027 (USD MILLION)
TABLE 46 INDIA: SPATIAL TRANSCRIPTOMICS MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 47 INDIA: SPATIAL GENOMICS ANALYSIS MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 48 INDIA: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
TABLE 49 INDIA: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
TABLE 50 INDIA: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY END USER, 2020-2027 (USD MILLION)
10.5 REST OF ASIA PACIFIC?
TABLE 51 REST OF ASIA PACIFIC: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY TECHNIQUE, 2020-2027 (USD MILLION)
TABLE 52 REST OF ASIA PACIFIC: SPATIAL TRANSCRIPTOMICS MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 53 REST OF ASIA PACIFIC: SPATIAL GENOMICS ANALYSIS MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 54 REST OF ASIA PACIFIC: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
TABLE 55 REST OF ASIA PACIFIC: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
TABLE 56 REST OF ASIA PACIFIC: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY END USER, 2020-2027 (USD MILLION)
11 COMPETITIVE LANDSCAPE (Page No. - 78)
11.1 INTRODUCTION?
11.2 RIGHT-TO-WIN STRATEGIES ADOPTED BY KEY PLAYERS?
FIGURE 21 SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET: STRATEGIES ADOPTED BY KEY PLAYERS
11.3 REVENUE SHARE ANALYSIS (TOP SIX PLAYERS)?
11.4 MARKET SHARE ANALYSIS (2021)?
11.5 COMPANY EVALUATION MATRIX?
11.5.1 STARS
11.5.2 EMERGING LEADERS
11.5.3 PERVASIVE PLAYERS
11.5.4 PARTICIPANTS
FIGURE 24 SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET: COMPANY EVALUATION MATRIX (2021)
11.6 COMPETITIVE SCENARIO AND TRENDS?
11.6.1 DEALS
TABLE 57 ASIA PACIFIC SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET: DEALS
11.6.1.1 Product launches
TABLE 58 ASIA PACIFIC SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET: PRODUCT LAUNCHES
11.6.1.2 Other developments
TABLE 59 ASIA PACIFIC SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET: OTHER DEVELOPMENTS
12 COMPANY PROFILES (Page No. - 86)
12.1 KEY PLAYERS?
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
12.1.1 NANOSTRING
TABLE 60 NANOSTRING: BUSINESS OVERVIEW
FIGURE 25 NANOSTRING: COMPANY SNAPSHOT (2021)
12.1.2 10X GENOMICS
TABLE 61 10X GENOMICS: BUSINESS OVERVIEW
FIGURE 26 10X GENOMICS: COMPANY SNAPSHOT (2021)
12.1.3 ILLUMINA
TABLE 62 ILLUMINA: BUSINESS OVERVIEW
FIGURE 27 ILLUMINA: COMPANY SNAPSHOT (2021)
12.1.4 BIO-RAD LABORATORIES, INC.
TABLE 63 BIO-RAD LABORATORIES, INC.: BUSINESS OVERVIEW
FIGURE 28 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2021)
12.1.5 BIO-TECHNE
TABLE 64 BIO-TECHNE: BUSINESS OVERVIEW
FIGURE 29 BIO-TECHNE: COMPANY SNAPSHOT (2021)
12.1.6 STANDARD BIOTOOLS
TABLE 65 STANDARD BIOTOOLS: BUSINESS OVERVIEW
FIGURE 30 STANDARD BIOTOOLS: COMPANY SNAPSHOT (2021)
12.1.7 AKOYA BIOSCIENCES
TABLE 66 AKOYA BIOSCIENCES: BUSINESS OVERVIEW
FIGURE 31 AKOYA BIOSCIENCES: COMPANY SNAPSHOT (2021)
12.1.8 S2 GENOMICS
TABLE 67 S2 GENOMICS: BUSINESS OVERVIEW
12.1.9 CANTATA BIO
TABLE 68 CANTATA BIO: BUSINESS OVERVIEW
12.1.10 VIZGEN CORP.
TABLE 69 VIZGEN: BUSINESS OVERVIEW
12.2 OTHER PLAYERS?
12.2.1 BGI GROUP
12.2.2 MILTENYI BIOTEC
12.2.3 BRUKER
12.2.4 PERKINELMER INC.
12.2.5 NOVOGENE CO., LTD.
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
13 APPENDIX (Page No. - 128)
13.1 DISCUSSION GUIDE?
13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL?
13.3 CUSTOMIZATION OPTIONS?
13.4 RELATED REPORTS?
13.5 AUTHOR DETAILS?